相关实验视频

Updated: Jul 6, 2025

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

一个成功治疗的COVID-19疫苗诱导了免疫性血栓塞缩性紫外线

Miguel A Rodriguez Guerra¹, Siddharth Chinta², Ana P Urena Neme³

¹Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, USA.

|January 4, 2024

概括

在接种COVID-19疫苗后,免疫性血栓塞缩性紫外线 (ITP) 可能发生. 早期检测和IVIG和类固醇治疗显著改善了患者的治疗结果.

科学领域:

免疫学免疫学免疫学
血液学血液学血液学
疫苗学疫苗学疫苗学

背景情况:

免疫性血栓塞性紫外线 (ITP) 是一种严重的自身免疫性出血疾病.
准确的诊断和及时的干预对于管理ITP和改善患者预后至关重要.

研究的目的:

在mRNA COVID-19疫苗接种后报告ITP病例.
强调早期诊断和治疗疫苗引起的ITP的重要性.
为了说明标准ITP治疗在疫苗相关病例中的有效性.

主要方法:

一份病例报告显示,一名61岁的肥胖女性患有严重的血小板缺血症.
在第二剂瑞-生物科技COVID-19疫苗接种后21天,ITP的诊断得到证实.
开始治疗的是静脉注射免疫球蛋白 (IVIG) 和高剂量德克萨米他.

主要成果:

这位患者的血小板数量非常低 (11k/ul).
血小板数显著增加到63k/ul在24小时内IVIG和甲.
在第二次IVIG剂量后,观察到进一步改善至122k/ul,趋势上升的轨迹.

结论:

在很少情况下,mRNA COVID-19 疫苗可以诱导免疫性血小板性紫外线.
早期检测和迅速治疗免疫球蛋白和皮质类固醇是有效的.
这一案例强调了在接种疫苗后诊断ITP时需要保持警,以确保最佳的患者结果.

关键词:

bnt162b2疫苗bnt162b2疫苗bnt162b2疫苗bnt162b2疫苗bnt162b2疫苗bnt162b2疫苗在Covid 19中,静脉注射免疫球蛋白 (IVIG) 的使用美国MRNA的COVID-19疫苗疫苗诱导的免疫血小板缺血症.

更多相关视频

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Vaccinations

Vaccinations